课题基金 / 基金详情

项目摘要

项目成果

ALOYSIUS John KLINGELHUTZ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Telomere shortening, a natural consequence of aging, and telomerase dysfunction have recently been linked with certain diseases associated with defects in highly proliferative tissue, including the epidermis. Our long-term goal is to understand the contribution of telomerase and telomere length in regulating the function and aging of human skin. Dyskeratosis congenita (DC) is an inherited "premature aging" syndrome characterized by epidermal abnormalities (e.g. leukoplakia, skin hypopigmentation, alopecia) and organ dysfunction (e.g. bone marrow failure, pulmonary fibrosis). DC is caused by mutations in genes that affect telomerase activity, resulting in shortening of telomeres in somatic cells. We recently identified an autosomal dominant form of this disease (AD DC) that is due to a deletion in hTERC, the RNA component of telomerase. AD DC provides a unique human model system to study the regulatory role of telomerase and telomere shortening in the biology of aging. We propose that telomerase and telomere length are important regulators of normal keratinocyte function, differentiation, and response to stress. Furthermore, we hypothesize that skin aging is associated with telomere length shortening and dysregulation of telomerase component expression. Using skin keratinocytes and fibroblasts isolated from AD DC subjects, normal controls and experimentally manipulated cells, we will further define the role of telomerase and telomere length in regulating DNA damage and oxidative stress response pathways. We will determine whether introduction of telomerase components, hTERC and/or hTERT, into AD DC cells restores replicative potential, cellular function, and normal responses to stress and DNA damage. We will also explore the possibility that hTERT has functions in keratinocytes that go beyond telomere maintenance and perform studies to determine whether the unusually long telomeres associated co-expression of hTERC and hTERT have any effects on cell phenotype. Overall, the experiments proposed in this application will further our understanding of the role of telomerase and telomeres in cellular defects associated with aging, and provide critical mechanistic insights into the processes that govern normal skin function and aging. Importantly, these findings may also promote the development of novel strategies aimed at reducing the effects of aging on human skin and other tissues, and in ameliorating the toxicity of cancer therapies in the elderly.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.virol.2011.12.018
发表时间: 2012-03-15
期刊: Virology
影响因子: 3.7
作者: [Klingelhutz AJ, Roman A]
通讯作者: Roman A
DOI: 10.1016/j.mrfmmm.2011.05.008
发表时间: 2012-02-01
期刊: MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
影响因子: 2.3
作者: [Gourronc, Francoise A., Klingelhutz, Aloysius J.]
通讯作者: Klingelhutz, Aloysius J.
Dyskeratosis Congenita Dermal Fibroblasts are Defective in Supporting the Clonogenic Growth of Epidermal Keratinocytes.
先天性角化不良真皮成纤维细胞在支持表皮角质形成细胞的克隆生长方面存在缺陷。
DOI: --
发表时间: 2012
期刊: Aging and disease
影响因子: 7.4
作者: [Buckingham,ErinM, Goldman,FrederickD, Klingelhutz,AloysiusJ]
通讯作者: Klingelhutz,AloysiusJ
The role of ISG15 and ISGylation in the senescence-associated secretory phenotype
  • 批准号:
    10788670
  • 项目类别:
  • 资助金额:
    $42.76万
  • 财政年份:
    2023
  • 负责人:
    ALOYSIUS John KLINGELHUTZ
  • 依托单位:
A Human Model for Telomerase Dysfunction and Aging
  • 批准号:
    7795131
  • 项目类别:
  • 资助金额:
    $26.79万
  • 财政年份:
    2007
  • 负责人:
    ALOYSIUS John KLINGELHUTZ
  • 依托单位:
A Human Model for Telomerase Dysfunction and Aging
  • 批准号:
    7586094
  • 项目类别:
  • 资助金额:
    $27.06万
  • 财政年份:
    2007
  • 负责人:
    ALOYSIUS John KLINGELHUTZ
  • 依托单位:
A Human Model for Telomerase Dysfunction and Aging
  • 批准号:
    7391533
  • 项目类别:
  • 资助金额:
    $27.06万
  • 财政年份:
    2007
  • 负责人:
    ALOYSIUS John KLINGELHUTZ
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: